Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997;336:1224‐34.
Article CAS PubMed Google Scholar
Gilotra N, Okada D, Sharma A, Chrispin J. Management of Cardiac Sarcoidosis in 2020. Arrhythm Electrophysiol Rev 2020;9:182‐8.
Article PubMed PubMed Central Google Scholar
Rathi VK, Biederman RW. Imaging of ventricular function by cardiovascular magnetic resonance. Curr Cardiol Rep 2004;6:55‐61.
Okune M, Yasuda M, Soejima N, Kagioka Y, Kakehi K, Kawamura T. Diagnostic utility of fusion (18)F-fluorodeoxyglucose positron emission tomography/cardiac magnetic resonance imaging in cardiac sarcoidosis. J Nucl Cardiol 2022;29:753‐64.
Livieratos L, Rajappan K, Stegger L, Schafers K, Bailey DL, Camici PG. Respiratory gating of cardiac PET data in list-mode acquisition. Eur J Nucl Med Mol Imaging 2006;33:584‐8.
Okuda K, Nakajima K. Has the era of dual-gated myocardial perfusion SPECT and PET arrived? J Nucl Cardiol 2020;27:648‐50.
Ishida Y, Yoshinaga K, Miyagawa M, Moroi M, Kondoh C, Kiso K, et al. Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations. Ann Nucl Med 2014;28:393‐403.
Machac J, Bacharach SL, Bateman TM, Bax JJ, Beanlands R, Bengel F, et al. Positron emission tomography myocardial perfusion and glucose metabolism imaging. J Nucl Cardiol 2006;13:e121‐51.
Terasaki F, Azuma A, Anzai T, Ishizaka N, Ishida Y, Isobe M, et al. JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis. Digest Version Circ J 2019;83:2329‐88.
Langah R, Spicer K, Gebregziabher M, Gordon L. Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis. J Nucl Cardiol 2009;16:801‐10.
Watanabe S, Hanaoka K, Shibata Y, Kaida H, Ishii K. Usefulness of respiratory-gated 18F-FDG PET/CT scan protocol in patients having positive myocardial 18F-FDG uptake. Nucl Med Commun 2019;40:235‐41.
Article CAS PubMed Google Scholar
Manabe O, Kroenke M, Aikawa T, Murayama A, Naya M, Masuda A, et al. Volume-based glucose metabolic analysis of FDG PET/CT: The optimum threshold and conditions to suppress physiological myocardial uptake. J Nucl Cardiol 2019;26:909‐18.
Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995;36:2138‐47.
Sharma OP, Maheshwari A, Thaker K. Myocardial sarcoidosis. Chest 1993;103:253‐8.
Article CAS PubMed Google Scholar
Miller RJH, Cadet S, Pournazari P, Pope A, Kransdorf E, Hamilton MA, et al. Quantitative assessment of cardiac hypermetabolism and perfusion for diagnosis of cardiac sarcoidosis. J Nucl Cardiol 2022;29:86‐96.
Tahara N, Tahara A, Nitta Y, Kodama N, Mizoguchi M, Kaida H, et al. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis. JACC Cardiovasc Imaging 2010;3:1219‐28.
Manabe O, Ohira H, Hirata K, Hayashi S, Naya M, Tsujino I, et al. Use of (18)F-FDG PET/CT texture analysis to diagnose cardiac sarcoidosis. Eur J Nucl Med Mol Imaging 2019;46:1240‐7.
Article CAS PubMed Google Scholar
Keall PJ, Kini VR, Vedam SS, Mohan R. Motion adaptive X-ray therapy: A feasibility study. Phys Med Biol 2001;46:1‐10.
Article CAS PubMed Google Scholar
Kamel E, Hany TF, Burger C, Treyer V, Lonn AH, von Schulthess GK, et al. CT vs 68Ge attenuation correction in a combined PET/CT system: Evaluation of the effect of lowering the CT tube current. Eur J Nucl Med Mol Imaging 2002;29:346‐50.
Article CAS PubMed Google Scholar
Kovalski G, Keidar Z, Frenkel A, Sachs J, Attia S, Azhari H. Dual, “motion-frozen heart” combining respiration and contraction compensation in clinical myocardial perfusion SPECT imaging. J Nucl Cardiol 2009;16:396‐404.
留言 (0)